TERAPET will take part in the 2026 ASTRO Annual Meeting, taking place from September 26 to 30, 2026, at the Thomas M. Menino Convention & Exhibition Center in Boston, Massachusetts.
Organized by the American Society for Radiation Oncology (ASTRO), the meeting will bring together more than 10,000 radiation oncologists, medical physicists, researchers, healthcare professionals and industry partners to explore the latest advances in radiation oncology, clinical practice and cancer care.
The 2026 edition will focus on the theme:
“Data to Dialogue: Communicating Radiotherapy’s Value to Advance Care“
The scientific and educational programme will feature more than 2,500 research presentations and posters covering advances in radiation medicine, clinical trials, emerging technologies and improvements in patient care.
TERAPET will be present at the Leo Cancer Care booth, showcasing our collaboration on integrated upright particle therapy workflows. Together, Leo Cancer Care and TERAPET are working to combine upright patient positioning and treatment delivery with PET-based in-vivo verification, supporting more precise, streamlined and patient-centred particle therapy.
Visitors will have the opportunity to learn more about QUALYSCAN® Upright and how PET-based treatment verification can be integrated into the upright workflow to provide additional insight into treatment delivery and support future adaptive radiation therapy strategies.
We look forward to meeting the radiation oncology and particle therapy communities at ASTRO 2026 in Boston.